Along with the progression of liver fibrosis, IGHV, GAPDH, C1s, GRP78 and V-ATPase levels significantly increased, and PPBP, CD9, Lp(a) and SAP levels significantly decreased (Fig 1B). This evidence concerns the gene GAPDH and Hepatic fibrosis.